Product image of Ebglyss (Lebrikizumab) supplied by GNH India

Ebglyss

Active Ingredient:
Lebrikizumab
Origin:
EU

Ebglyss (Lebrikizumab)

Ebglyss (lebrikizumab) is a subcutaneous medication used to manage moderate-to-severe atopic dermatitis. This biologic therapy targets specific immune responses to help reduce inflammation and improve skin condition.

Manufacturer / TM Owner

Almirall, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ebglyss is primarily used for the treatment of moderate-to-severe atopic dermatitis in adults. This condition, also known as eczema, involves chronic inflammation and itching of the skin. Lebrikizumab works by targeting specific proteins involved in the immune response, helping to alleviate symptoms and improve skin health. Patients often seek lebrikizumab for its potential to provide long-term relief from persistent skin issues.

Side Effects

  • Common effects of Ebglyss may include reactions at the injection site, such as redness, itching, or swelling. Some users might experience headaches, fatigue, or upper respiratory infections. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Ebglyss should be used with caution in individuals with a history of allergic reactions to lebrikizumab or similar medications. It is important to follow proper subcutaneous administration techniques to minimize the risk of infection. Patients should also be monitored for any signs of worsening skin conditions or new skin infections while using this medication.

Avoid Interactions

  • Ebglyss may interact with other medications that affect the immune system, including certain biologics or immunosuppressants. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Additionally, alcohol or other substances that may weaken the immune system should be used cautiously while on lebrikizumab therapy.

Frequently Asked Questions

Ebglyss is used to treat moderate-to-severe atopic dermatitis, helping to reduce inflammation and improve skin condition.

Ebglyss is administered via subcutaneous injection, typically self-administered after proper training.

Common side effects include injection site reactions, headaches, fatigue, and upper respiratory infections.

Ebglyss may interact with other immune-affecting medications, so it's important to consult a healthcare provider before combining treatments.

Individuals with a history of allergic reactions to lebrikizumab or similar medications should avoid using Ebglyss.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lebrikizumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT